Research and development (R&D) plays a pivotal role in the discovery and development of innovative medicines, treatments, and diagnostic tools. At Cardiaan, we believe that in the ocean of medical sciences only a drop of its true potential has been achieved and the rest is yet left untapped. The R&D encompasses a wide range of activities, from basic research to clinical trials, and involves collaboration between scientists, clinicians, and other professionals. The primary objective of R&D in the pharmaceutical industry is to improve human health by addressing unmet medical needs and advancing the understanding of diseases and their treatments.
The research and development at Cardiaan Life Sciences can be divided into several stages, each with its unique focus and challenges. The initial stage is known as the discovery phase, where scientists explore potential drug targets and mechanisms. This may involve studying the molecular and cellular basis of diseases, identifying disease-related biomarkers, or screening natural compounds for therapeutic properties. The goal is to identify promising drug candidates that can be further developed into effective treatments.
Cardiaan Life Sciences works closely in collaboration with some of the leading pharmaceutical manufacturing companies across the country and beyond to help accelerate conception, creation, testing and deployment of various medical betterments. If the drug candidate successfully passes all phases of clinical trials, it proceeds to the final stage, known as regulatory approval.
Regulatory approval involves submitting the clinical trial data and other relevant information to regulatory agencies. These agencies review the data to ensure the drug's safety and efficacy before granting marketing authorization. Once approved, the drug can be manufactured and distributed for medical use. Post-marketing surveillance is another crucial aspect of pharmaceutical R&D. This involves monitoring the drug's safety and efficacy in real-world settings, as well as identifying any unforeseen side effects. This information is used to update product labels, inform prescribing practices, and potentially lead to further research and development of the drug or related therapies.